Tostran: Phase IV started

Cancer Research UK (London, U.K.) began a double-blind, placebo-controlled, U.K. Phase IV trial to evaluate Tostran daily for 26 weeks in about 270 male cancer survivors aged 25-50. Kyowa's ProStrak...